destiny pharma (brighton) limited
destiny pharma (brighton) limited Company Information
Company Number
10517676
Next Accounts
153 days late
Shareholders
destiny pharma plc
Group Structure
View All
Industry
Other research and experimental development on natural sciences and engineering
Registered Address
unit 36 sussex innovation centre, science park square, falmer, brighton, BN1 9SB
Website
www.destinypharma.comdestiny pharma (brighton) limited Estimated Valuation
Pomanda estimates the enterprise value of DESTINY PHARMA (BRIGHTON) LIMITED at £0 based on a Turnover of £0 and 1.28x industry multiple (adjusted for size and gross margin).
destiny pharma (brighton) limited Estimated Valuation
Pomanda estimates the enterprise value of DESTINY PHARMA (BRIGHTON) LIMITED at £0 based on an EBITDA of £0 and a 5.86x industry multiple (adjusted for size and gross margin).
destiny pharma (brighton) limited Estimated Valuation
Pomanda estimates the enterprise value of DESTINY PHARMA (BRIGHTON) LIMITED at £2 based on Net Assets of £1 and 2.03x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Destiny Pharma (brighton) Limited Overview
Destiny Pharma (brighton) Limited is a live company located in falmer, BN1 9SB with a Companies House number of 10517676. It operates in the other research and experimental development on natural sciences and engineering sector, SIC Code 72190. Founded in December 2016, it's largest shareholder is destiny pharma plc with a 100% stake. Destiny Pharma (brighton) Limited is a young, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Destiny Pharma (brighton) Limited Health Check
There is insufficient data available to calculate a health check for Destiny Pharma (Brighton) Limited. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Destiny Pharma (brighton) Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Destiny Pharma (brighton) Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- Destiny Pharma (brighton) Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Destiny Pharma (brighton) Limited
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - Destiny Pharma (brighton) Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Destiny Pharma (brighton) Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Destiny Pharma (brighton) Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Destiny Pharma (brighton) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Destiny Pharma (brighton) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Destiny Pharma (brighton) Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Destiny Pharma (brighton) Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Destiny Pharma (brighton) Limited
- - Industry AVG
DESTINY PHARMA (BRIGHTON) LIMITED financials
Destiny Pharma (Brighton) Limited's latest turnover from December 2022 is estimated at 0 and the company has net assets of £1. According to their latest financial statements, we estimate that Destiny Pharma (Brighton) Limited has no employees and maintains cash reserves of £1 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | ||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|
| Tangible Assets | ||||||
| Intangible Assets | ||||||
| Investments & Other | ||||||
| Debtors (Due After 1 year) | ||||||
| Total Fixed Assets | ||||||
| Stock & work in progress | ||||||
| Trade Debtors | ||||||
| Group Debtors | ||||||
| Misc Debtors | ||||||
| Cash | 1 | 1 | 1 | 1 | ||
| misc current assets | ||||||
| total current assets | 1 | 1 | 1 | 1 | ||
| total assets | 1 | 1 | 1 | 1 | ||
| Bank overdraft | ||||||
| Bank loan | ||||||
| Trade Creditors | ||||||
| Group/Directors Accounts | ||||||
| other short term finances | ||||||
| hp & lease commitments | ||||||
| other current liabilities | ||||||
| total current liabilities | ||||||
| loans | ||||||
| hp & lease commitments | ||||||
| Accruals and Deferred Income | ||||||
| other liabilities | ||||||
| provisions | ||||||
| total long term liabilities | ||||||
| total liabilities | ||||||
| net assets | 1 | 1 | 1 | 1 | ||
| total shareholders funds | 1 | 1 | 1 | 1 |
| Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | ||||||
| Amortisation | ||||||
| Tax | ||||||
| Stock | ||||||
| Debtors | ||||||
| Creditors | ||||||
| Accruals and Deferred Income | ||||||
| Deferred Taxes & Provisions | ||||||
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | ||||||
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | ||||||
| Group/Directors Accounts | ||||||
| Other Short Term Loans | ||||||
| Long term loans | ||||||
| Hire Purchase and Lease Commitments | ||||||
| other long term liabilities | ||||||
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 1 | |||||
| overdraft | ||||||
| change in cash | 1 |
destiny pharma (brighton) limited Credit Report and Business Information
Destiny Pharma (brighton) Limited Competitor Analysis
Perform a competitor analysis for destiny pharma (brighton) limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other young companies, companies in BN1 area or any other competitors across 12 key performance metrics.
destiny pharma (brighton) limited Ownership
DESTINY PHARMA (BRIGHTON) LIMITED group structure
Destiny Pharma (Brighton) Limited has no subsidiary companies.
Ultimate parent company
1 parent
DESTINY PHARMA (BRIGHTON) LIMITED
10517676
destiny pharma (brighton) limited directors
Destiny Pharma (Brighton) Limited currently has 2 directors. The longest serving directors include Dr William Love (Dec 2016) and Mr Shaun Claydon (May 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr William Love | 62 years | Dec 2016 | - | Director | |
| Mr Shaun Claydon | England | 56 years | May 2023 | - | Director |
P&L
December 2022turnover
0
0%
operating profit
-0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2022net assets
1
0%
total assets
1
0%
cash
1
0%
net assets
Total assets minus all liabilities
Similar Companies
destiny pharma (brighton) limited company details
company number
10517676
Type
Private limited with Share Capital
industry
72190 - Other research and experimental development on natural sciences and engineering
incorporation date
December 2016
age
9
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
December 2022
previous names
destiny pharma limited (August 2017)
destiny pharma (brighton) limited (January 2017)
accountant
-
auditor
-
address
unit 36 sussex innovation centre, science park square, falmer, brighton, BN1 9SB
Bank
-
Legal Advisor
-
destiny pharma (brighton) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to destiny pharma (brighton) limited.
destiny pharma (brighton) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DESTINY PHARMA (BRIGHTON) LIMITED. This can take several minutes, an email will notify you when this has completed.
destiny pharma (brighton) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
